TNGX - Tango Therapeutics Inc
IEX Last Trade
11.81
0.690 5.843%
Share volume: 893,316
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$11.12
0.69
6.21%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-10 | 2022-11-10 | 2023-03-27 | 2023-05-09 | 2023-08-07 | 2023-11-08 | 2024-03-18 | 2024-05-08 | |
| Total revenue | 5.771 M | 6.920 M | 6.411 M | 5.766 M | 14.598 M | 10.732 M | 5.431 M | 6.471 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 5.771 M | 6.920 M | 6.411 M | 5.766 M | 14.598 M | 10.732 M | 5.431 M | 6.471 M | |
| 19.91% | -7.36% | -10.06% | 153.17% | -26.48% | -49.39% | 19.15% | |||
| Operating expenses | 30.973 M | 36.843 M | 36.978 M | 36.052 M | 37.845 M | 36.358 M | 40.445 M | 48.726 M | |
| Selling general and admin | 7.232 M | 8.099 M | 7.887 M | 8.013 M | 9.174 M | 9.209 M | 9.106 M | 10.661 M | |
| Research and development | 23.741 M | 28.744 M | 29.091 M | 28.039 M | 28.671 M | 27.149 M | 31.339 M | 38.065 M | |
| Total expenses | 30.973 M | 36.843 M | 36.978 M | 36.052 M | 37.845 M | 36.358 M | 40.445 M | 48.726 M | |
| 18.95% | 0.37% | -2.50% | 4.97% | -3.93% | 11.24% | 20.47% | |||
| Operating income | -25.202 M | -29.923 M | -30.567 M | -30.286 M | -23.247 M | -25.626 M | -35.014 M | -42.255 M | |
| Ebit | -25.202 M | -29.923 M | -30.567 M | -30.286 M | -23.247 M | -25.626 M | -35.014 M | -42.255 M | |
| Pretax income | -24.855 M | -29.050 M | -29.009 M | -28.008 M | -20.646 M | -22.240 M | -30.716 M | -37.874 M | |
| 16.88% | -0.14% | -3.45% | -26.29% | 7.72% | 38.11% | 23.30% | |||
| Income tax | 3.000 K | 0.000 | 51.000 K | 0.000 | 64.000 K | 23.000 K | 47.000 K | 40.000 K | |
| Net income basic | -24.858 M | -29.050 M | -29.060 M | -28.008 M | -20.710 M | -22.263 M | -30.763 M | -37.914 M | |
| -16.86% | -0.03% | 3.62% | 26.06% | -7.50% | -38.18% | -23.25% | |||
| Net income | -24.858 M | -29.050 M | -29.060 M | -28.008 M | -20.710 M | -22.263 M | -30.763 M | -37.914 M | |
| -16.86% | -0.03% | 3.62% | 26.06% | -7.50% | -38.18% | -23.25% |